PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
News|Articles|January 22, 2014
InformEx 2014 Kicks Off in Miami Beach
Author(s)Pharmaceutical Technology Editors
InformEx, North America's business partnering event for buyers and sellers of high-value chemistry, has launched the 30th edition of its annual conference at the Miami Beach Convention Center.
Advertisement
InformEx, North America's business partnering event for buyers and sellers of high-value chemistry, has launched the 30th edition of its annual conference at the Miami Beach Convention Center. The conference continues through Jan. 24, featuring on-site education sessions and daily networking events geared toward helping attendees grow their business and prepare for the changing marketplace.
More than 3,500 attendees from top pharmaceutical, fine chemical and specialty chemical companies are taking part in the conference. On-floor education sessions allow attendees to learn about key topics such as green chemistry, opportunities in pharma, personalized medicine, compliance, 3-D printing and more.
Kicking off the conference sessions on Jan. 22 will be a special presentation by Dr. Donna Nelson, University of Oklahoma organic chemistry professor who was a scientific consultant for the Emmy-winning series "Breaking Bad" since its second season. Dr. Nelson will share stories of how she turned her chemistry knowledge into plot-enhancing details for what has been one of the most successful shows of the last decade.
Advertisement
Related to this article
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Advertisement
Advertisement